Therapeutic Goods Administration Grants Provisional Approval for Moderna's COVID-19 Vaccine in Children Aged Six Months to Five YearsAccesswire • 07/19/22
Moderna's COVID-19 vaccine OK'd in Canada for children aged 6 months and olderMarket Watch • 07/14/22
Health Canada Authorizes Moderna's COVID-19 Vaccine in Young Children (6 Months-5 Years)Accesswire • 07/14/22
Moderna (MRNA) Announces First Participant In Phase 1 Trial Of Nipah Virus Vaccine mRNA-1215Pulse2 • 07/12/22
Moderna Announces First Participant Dosed in a Phase 1 Trial of its Nipah Virus mRNA Vaccine, mRNA-1215Accesswire • 07/12/22
New omicron variant worries experts as it spreads in India, and Moderna says new booster offers better protection against BA.4 and BA.5Market Watch • 07/11/22
Moderna says one of its COVID-19 booster candidates better protects against BA.4 and BA.5Market Watch • 07/11/22
Moderna's Omicron-Containing Bivalent Booster Candidate, mRNA-1273.214, Demonstrates Significantly Higher Neutralizing Antibody Response Against Omicron Subvariants BA.4/5 Compared To Currently Authorized BoosterAccesswire • 07/11/22